← Back to Search

tDCS for Cognitive Enhancement in Healthy Subjects (Normal_tDCS Trial)

N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate (less than 60 minutes)
Awards & highlights

Normal_tDCS Trial Summary

This trial is testing the effects of tDCS on cognition in healthy volunteers.

Who is the study for?
This trial is for healthy volunteers without any history of neurological or psychiatric diseases, abnormal MRI results, metal implants, pacemakers, severe hypertension, cardiovascular disease or family history of epilepsy. Pregnant or breastfeeding women are also excluded.Check my eligibility
What is being tested?
The study tests the effects of transcranial direct current stimulation (tDCS) on brain function. Participants will undergo neuropsychological tests and brain imaging while receiving either real tDCS to left or right prefrontal cortex or sham (fake) tDCS.See study design
What are the potential side effects?
Potential side effects from tDCS may include mild discomfort at the stimulation site, itching, tingling sensation during application, headache after treatment and fatigue.

Normal_tDCS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate (less than 60 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate (less than 60 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
functional connectivity
Secondary outcome measures
Stroop task performance

Normal_tDCS Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Real Left DLPFC tDCSActive Control1 Intervention
Real tDCS on the left dorsolateral prefrontal cortex
Group II: Real Right DLPFC tDCSActive Control1 Intervention
Real tDCS on the right dorsolateral prefrontal cortex
Group III: Sham tDCSPlacebo Group1 Intervention
30sec ramp-up and 30sec ramp-down

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
592 Previous Clinical Trials
199,330 Total Patients Enrolled

Media Library

Real Left DLPFC tDCS Clinical Trial Eligibility Overview. Trial Name: NCT03027869 — N/A
Healthy Subjects Research Study Groups: Real Left DLPFC tDCS, Sham tDCS, Real Right DLPFC tDCS
Healthy Subjects Clinical Trial 2023: Real Left DLPFC tDCS Highlights & Side Effects. Trial Name: NCT03027869 — N/A
Real Left DLPFC tDCS 2023 Treatment Timeline for Medical Study. Trial Name: NCT03027869 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial still have room for more participants?

"Unfortunately, this study is not currently enrolling patients. Although, this was a recruiting study at one point in time, the last update to the posting on clinicaltrials.gov was on October 31st, 2022. There are 1,019 other trials that are actively recruiting patients right now."

Answered by AI
~5 spots leftby Mar 2025